Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
2.21
-0.11 (-4.74%)
At close: Oct 06, 2025, 10:13 AM
-4.74% (1D)
| Bid | 2.18 |
| Market Cap | 73.35M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -67.81M |
| EPS (ttm) | -2.2 |
| PE Ratio (ttm) | -1 |
| Forward PE | -2.69 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 2.26 |
| Volume | 130,960 |
| Avg. Volume (20D) | 732,375 |
| Open | 2.36 |
| Previous Close | 2.32 |
| Day's Range | 2.16 - 2.38 |
| 52-Week Range | 0.24 - 3.98 |
| Beta | 0.92 |
| Ex-Dividend Date | n/a |
About RLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RLMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RLMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
-9.03%
Relmada Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
